NCT00798382

Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 154 (actual)
• Sponsor: Abbott Nutrition · Industry
• Sex: All
• Age: 8 Days
• Healthy volunteers: Accepted

Summary

The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.

Conditions

• Infant, Newborn

Interventions

Type	Name	Description
OTHER	soy protein formula	ad lib for 0-35 days of age
OTHER	Commercially available soy formula	ad lib for 0-35 days of age
OTHER	Soy formula experimental #2	ad lib for 0-35 days of age

Timeline

• Start date: 2008-12-01
• Primary completion: 2009-04-01
• Completion: 2009-09-01
• First posted: 2008-11-26
• Last updated: 2012-06-14

Locations

17 sites across 1 country: United States